Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation

American Journal of Transplantation

Volumn 3, Issue 10, 2003, Pages 1289-1294

  Karthikeyan, Vanji ^a   Parasuraman, Raviprasenna ^a   Shah, Veena ^a   Vera, Edgard ^a   Venkat, K K ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Calcineurin inhibitor; HUS; Plasma exchange; Renal; Thrombotic microangiopathy; TMA; Transplantation; TTP

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN; HEMOGLOBIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID; OKT 3; TACROLIMUS; THROMBOXANE A2; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; PATHOGENESIS; PLASMAPHERESIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; RECURRENT DISEASE; RELIABILITY; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INFECTION;

ADULT; BIOPSY; BLOOD PLATELETS; CALCINEURIN; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA EXCHANGE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0141781175     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00222.x     Document Type: Article

References (44)

1. Agarwal A, Matas AJ, Nath KA. Recurrent hemolytic uremic syndrome in an adult renal allograft recipient. J Am Soc Nephrol 1995; 6: 1160-1169.
2. Schmidt RJ, Venkat KK, Dumler F. Hemolytic uremic syndrome in a renal transplant recipient on FK immunosuppression. Transplant Proc 1991; 23: 3156-3157.
3. Pham TP, Peng A, Wilkinson A. Cyclosporine and Tacrolimus associated thrombotic microangiopathy. Am J Kidney Dis 2000; 36: 4.
4. Shulman H, Striker G, Deeg HJ, Kennedy M, Storb R, Thomas ED. Nephrotoxicity of cyclosporine A after allogenic bone marrow transplantation. N Engl J Med 1981; 305: 1393-1395.
5. Powles RL, Clink HM, Spence D et al. Cyclosporine A to prevent graft-versus-host disease in man after allogenic bone marrow transplantation. Lancet 1980; 1: 327-329.
6. Ruggenenti P, Remuzzi G. Thrombotic microangiopathies. Crit Rev Oncol Hematol 1991; 11: 243-265.
7. Beaufils H, de Groc F, Gubler MC et al. Haemolytic uraemic syndrome in patients with Bechet's disease treated with cyclosporine A: report of two cases. Clin Nephrol 1990; 34: 157-162.
8. Hochstetler LA, Flanigan MJ, Lager DJ. Transplant associated thrombotic microangiopathy. The role of IgG administration as initial therapy. Am J Kidney Dis 1994; 23: 444-450.
9. Trimarchi HM, Truong LD, Brennan S, Gonzalez JM, Suki WN. FK associated thrombotic microangiopathy: Report of two cases and review of the literature. Transplantation 1999; 67: 539-544.
10. Wiener Y, Nakhleh RE, Lee M et al. Prognostic factors and early resumption of cyclosporine A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome. Clin Transplant 1997; 11: 157-162.
11. Lecornu-Heuze L, Ducloux D, Rebibou JM, Martin L, Billerey C, Chalopin JM. Mycophenolate mofetil in cyclosporine-associated thrombotic microangiopathy. Nephrol Dial Transplant 1998; 13: 3212-3213.
12. van der Molen LR, van Son WJ, Tegzess AM, Stegeman CA. Severe vital depression as the presenting feature of cyclosporine-associated thrombotic microangiopathy. Nephrol Dial Transplant 1999;14:998-1000.
13. Sommer BG, Henry ML, Ferguson RM. Obliterative renal arteriopathy following cyclosporine therapy. Transplant Proc 1986; 17: 1285-1286.
14. Giroux L, Smeesters C, Corman J et al. Hemolytic uremic syndrome in renal allografted patients treated with cyclosporine: Can J Physiol Pharmacol 1987; 65: 1125-1131.
15. Young BA, Marsh CL, Alpers CE, Davis CL. Cyclosporine associated Thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis 1996; 28: 561-571.
16. Noel C, Saunier P, Hazzan M et al. Incidence and clinical profile of micro vascular complications of in renal allografted patients treated with cyclosporine. Ann Intern Med 1992; 143 (Suppll): 33-36.
17. Candinas D, Keusch G, Schlumpf R, Burger HR, Weder W, Largiader F. Prognostic factors of hemolytic uremic syndrome in renal allografts. Transplant Proc 1993; 25: 1041-1042.
18. Rock GA, Shumak KH, Buskard NA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325: 393-397.
19. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000; 96: 1223-1229.
20. Schlanger RE, Henry ML, Sommer BG, Ferguson RM. Identification and treatment of cyclosporine associated allograft thrombosis. Surgery 1986; 100: 329-333.
21. Venkat KK, Tkach D, Kupin W et al. Reversal of cyclosporine associated hemolytic uremic syndrome by plasma exchange with fresh frozen plasma replacement in renal transplant recipients. Transplant Proc 1991; 23: 1256-1257.
22. Murer L, Zacchello G, Bianchi D et al. Thrombotic microangiopathy associated with Parvovirus B19 infection after renal transplantation. J Am soc Nephrol 2000; 11: 1132-1137.
23. Mor E, Lustig A, Tovar N et al. Thrombotic Microangiopathy early after kidney transplantation: Hemolytic Uremic Syndrome or vascular rejection? Transplantation Proc 2000; 32: 686-687.
24. Ruggenenti P, Noris A, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60: 831-851.
25. Schlumpf R, Candinas D, Weder W et al. Acute vascular rejection with hemolytic uremic syndrome in kidneys from non heart beating donors: associated with secondary grafts and early cyclosporine treatment? Transplantation 1993; 25: 1518.
26. Jecjeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy. Transplantation 1998; 65: 1645-1648.
27. Boccia RV, Gelmann EP, Baker CC, Marti G, Longo DL. A hemolytic uremic syndrome with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 716-717.
28. Kovach MJ, Soong Chin-Yee IH. Thrombotic thrombocytopenic purpura associated with Ticlopidine. Ann Pharmacother 1993; 27: 1060-1061.
29. Caggiano V, Choseny B, Way LW. Thrombotic thrombocytopenic purpura, cholangiocarcinoma and oral contraceptives (letter). Lancet 1980; 2: 365.
30. Shultz P, Raij L. Endogenously synthesized nitric oxide prevents endotoxin induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-1725.
31. Neild GH, Rocchi G, Imberti L. Effect of cyclosporine an on prostacyclin synthesis by vascular tissue. Thromb Res 1983; 32: 373-379.
32. Brown Z, Neild GH. Cyclosporine inhibits prostacyclin production by cultured human endothelial cells. Transplant Proc 1987; 19: 1178-1180.
33. Remuzzi G, Bertani T. Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 1989; 18: 261-272.
34. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporine induced endothelial injury. Lab Invest 1986; 55: 445-462.
35. Singh N, Gayowski T, Marino IR. Hemolytic uremic syndrome in solid organ transplant recipients. Transplant Int 1996; 9: 68-75.
36. Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross match positive recipients. Transplantation 2000; 27 (70): 887-895.
37. Singer K. Thrombotic thrombocytopenic purpura. Adv Intern Med 1954; 6: 195-234.
38. Amorosi E, Lultmann JE. Thrombotic thrombocytopenic purpura report of 16 cases and review of literature. Medicine (Baltimore) 1966; 45: 139-159.
39. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: Clinical experience in 108 patients. N Engl J Med 1991; 325: 398-403.
40. Verpooten GA, Paulus GJ, Roels F, De Broe ME. De novo occurrence of hemolytic uremic syndrome in a Cyclosporine treated renal allograft patient. Transplant Proc 1987; 2: 2943-2945.
41. Buturovic J, Kandus A, Malvorh M, Bren A, Drinovec J. Cyclosporine associated hemolytic uremic syndrome in four renal allograft recipients: Resolution without specific therapy. Transplant Proc 1990; 22: 1726-1727.
42. Dussol B, Brunet P, Vacher-Coponat Hsaingra Y, Casanova P, Berland Y. Hemolytic uremic syndrome in a renal transplant recipient during OKT3 therapy. Nephrol Dial Transplant 1994; 9: 1191-1193.
43. Van Buren D, Van Buren CT, Flechner SM, Maddox AM, Verani R, Kahan BD. De novo hemolytic uremic syndrome in renal transplant recipient's immunosuppressed with cyclosporine. Surgery 1985; 98: 54-62.
44. Byrnes JJ, Moake JL. Thrombotic thrombocytopenic purpura and the haemolytic uraemic syndrome. Evolving concepts of pathogenesis and therapy. Clin Haematol 1986; 15: 413-441.